首页> 美国卫生研究院文献>Oncotarget >WT1 p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis

【2h】

WT1 p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis

机译：WT1p53和p16表达在低度和高度浆液性卵巢癌的诊断中及其与预后的关系

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectiveTo evaluate the diagnostic and prognostic value of the immunohistochemical expression of WT1, p53 and p16 in low- (LGSOCs) and high-grade serous ovarian carcinomas (HGSOCs).

机译：目的探讨WT1，p53和p16的免疫组织化学表达在低（LGSOCs）和高级别浆液性卵巢癌（HGSOCs）中的诊断和预后价值。

著录项

期刊名称 Oncotarget
作者
Luis Felipe Sallum; Liliana Andrade; Susana Ramalho; Amanda Canato Ferracini; Rodrigo de Andrade Natal; Angelo Borsarelli Carvalho Brito; Luis Otávio Sarian; Sophie Derchain;
展开▼
作者单位

展开▼
年(卷),期 2018(9),22
年度 2018
页码 15818–15827
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;细胞生物学;
关键词
cystadenocarcinoma serous diagnoses survival prognosis Pathology;

机译：膀胱腺癌;浆液性;诊断;生存;预后;病理;

相似文献

外文文献
中文文献
专利

1. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour. [J] . ONeill CJ, McBride HA, Connolly LE, Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2007,第6期

机译：高级别卵巢浆液性癌表现出比低级别浆液性癌和浆液性交界性肿瘤明显更高的p16表达。
2. BRCA1, Ki67, and -Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma [J] . Sallum Luis Felipe, Andrade Liliana, Eloy da Costa Larissa Bastos, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2018,第3期

机译：BRCA1，KI67和-Catenin免疫表达与患有低和高级浆液癌癌的妇女的分化，铂反应或预后无关
3. Targeted Genomic Sequencing Reveals Novel TP53 In-frame Deletion Mutations Leading to p53 Overexpression in High-grade Serous Tubo-ovarian Carcinoma [J] . Jung Yoon Yang, Woo Ha Young, Kim Hyun-Soo Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第6期

机译：靶向基因组测序揭示了新型TP53内缺失突变，导致高级浆液卵巢癌癌的P53过表达
4. Global proteomic analysis of ovarian high-grade serous carcinomas using SWATH-MS for targeted verification of proteome changes associated with genomic alterations [C] . Stefani N. Thomas, Jing Chen, Paul Aiyetan, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：卵巢高级浆液癌的全局蛋白质组学分析使用SWATH-MS进行靶向验证与基因组改变相关的蛋白质组变化
5. Inhibitory Functions of SUSD2 in the Progression of High-Grade Serous Ovarian Carcinoma. [D] . Sheets, Jordan N. 2017

机译：SUSD2在高级浆液性卵巢癌进展中的抑制作用。
6. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target [O] . Hanzhi Wang, Feng Ye, Caiyun Zhou, 2021

机译：高级浆液卵巢癌中ENPP1的高表达预测预后差和分子治疗目标
7. WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis [O] . Luis Felipe Sallum, Liliana Andrade, Susana Ramalho, 2018

机译：WT1，p53和p16表达在低级浆液卵巢癌的诊断及其与预后的关系中

WT1 p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅